Screener

Eligibility screening

JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer

Sponsored by Johnson & Johnson Enterprise Innovation Inc.Study detailsClinicalTrials.gov

15 US sites in CT, FL, GA, NC +7

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.